Medicare Part D drug Data year 2024 Generic name Source: CMS Part D Prescribers

Insulin Glargine-Yfgn

Open in the dashboard

Part D claims

290,559

Prescriptions dispensed, refills included

Drug cost

$23,754,749

Paid at the pharmacy, in all

Prescribers

9,665

With 11 or more claims of it

In 2024, Medicare Part D recorded 290,559 claims for Insulin Glargine-Yfgn from 9,665 prescribers, at a total drug cost of $23.8 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 55 states and territories
Part D claims for Insulin Glargine-Yfgn by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 2,531 75,705 $8,584,449
FL 549 26,056 $1,367,601
PR 406 13,285 $1,204,913
CO 379 12,441 $1,233,767
NY 465 11,378 $636,603
PA 335 11,149 $665,377
WA 422 9,824 $1,010,675
TX 368 9,331 $555,374
MI 255 9,058 $574,766
VA 249 7,665 $570,477
MD 216 6,563 $647,832
NC 213 6,431 $278,967
IL 232 6,210 $389,110
IN 175 5,950 $300,716
OR 227 5,881 $644,597
The other 40 states and territories
State Prescribers Claims Drug cost
WI 230 5,690 $577,759
GA 167 5,477 $477,778
NM 203 5,444 $516,377
OH 182 5,384 $249,757
OK 131 5,195 $469,014
TN 141 4,200 $180,999
MA 147 4,138 $237,119
NJ 197 4,025 $243,776
KY 107 2,902 $142,351
HI 82 2,839 $307,560
AZ 112 2,541 $139,500
MO 88 2,388 $137,453
CT 89 2,044 $110,684
SC 77 2,042 $101,555
WV 47 2,039 $77,088
MN 74 1,874 $105,287
KS 53 1,748 $117,190
AR 53 1,366 $107,971
IA 47 1,218 $84,844
ID 35 1,198 $69,432
AL 47 1,187 $66,924
UT 31 1,034 $61,049
MS 33 958 $45,273
NV 40 925 $48,349
RI 23 895 $48,423
DC 31 799 $86,652
LA 29 785 $64,022
NE 20 550 $34,532
NH 25 528 $30,727
ME 28 517 $31,051
DE 20 490 $25,671
VT 13 297 $12,580
ND 13 268 $26,128
MT 14 239 $13,276
SD 3 149 $16,085
WY 3 75 $3,106
AK 5 64 $7,854
GU 1 54 $5,773
ZZ 1 39 $3,864
AE 1 27 $4,694

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 55
Part D claims for Insulin Glargine-Yfgn by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Internal Medicine 3,431 103,697 $7,794,506
Family Practice 3,028 78,707 $6,592,356
Nurse Practitioner 1,506 46,621 $3,228,213
Pharmacist 379 19,217 $2,696,752
Endocrinology 226 9,413 $1,105,233
General Practice 300 8,664 $669,730
Physician Assistant 251 6,970 $668,698
Geriatric Medicine 163 4,903 $246,191
Hospitalist 125 4,048 $212,522
Emergency Medicine 51 1,892 $98,446
Family Medicine 27 1,417 $112,768
Nephrology 25 654 $61,430
Student in an Organized Health Care Education/Training Program 18 569 $50,039
Physical Medicine and Rehabilitation 10 490 $17,615
Hospice and Palliative Care 19 485 $22,265

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Antonio Marrero Nurse Practitioner FL 1,988 $104,782 None on record
Janet Martinez Nurse Practitioner FL 1,238 $61,544 None on record
Valentina Salvat Garcia Nurse Practitioner FL 709 $40,846 None on record
Daniela Dicenso Internal Medicine FL 649 $39,493 None on record
Kelly George Internal Medicine OR 467 $51,905 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for insulin glargine-yfgn

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record